Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

June 26, 2020

Study Completion Date

June 26, 2020

Conditions
Mucopolysaccharidoses
Interventions
OTHER

Sputum

Sputum will be collected after a respiratory physiotherapy session, scheduled as part of routine care.

OTHER

Tracheal aspiration

Tracheal aspirations will be collected in intubated patients (intubation for surgery under general anesthesia).

Trial Locations (7)

Unknown

Metabolic Disease Competence Centre - Medical Genetics Department - University Hospital, Angers, Angers

Metabolic Disease Reference Centre - Medical Genetics Department - University Hospital, Bordeaux, Bordeaux

Metabolic Disease Competence Centre - Medical Genetics Department - University Hospital, Brest, Brest

Metabolic Disease Competence Centre - Pediatrics Department - University Hospital, Rennes, Rennes

Metabolic Disease Reference Centre - Pediatrics Department - University Hospital, Toulouse, Toulouse

Metabolic Disease Reference Centre - Pediatrics Department - University Hospital, Tours, Tours

Pediatric Resuscitation Unit - Universty Hospital, Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT04112602 - Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis | Biotech Hunter | Biotech Hunter